Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report

BACKGROUND: Neurofilament Light (NfL) chain levels in both cerebrospinal fluid (CSF) and serum have been correlated with the reduction of axonal damage in multiple sclerosis (MS) patients treated with Natalizumab (NTZ). However, little is known about the function of plasmacytoid cells in NTZ-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Moraes, Adriel S., Boldrini, Vinicius O., Dionete, Alliny C., Andrade, Marilia D., Longhini, Ana Leda F., Santos, Irene, Lima, Amanda D. R., Silva, Veronica A. P. G., Dias Carneiro, Rafael P. C., Quintiliano, Raphael P. S., Ferrari, Breno B., Damasceno, Alfredo, Pradella, Fernando, Farias, Alessandro S., Tilbery, Charles P., Domingues, Renan B., Senne, Carlos, Fernandes, Gustavo B. P., von Glehn, Felipe, Brandão, Carlos Otavio, Stella, Carla R. A. V., Santos, Leonilda M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350727/
https://www.ncbi.nlm.nih.gov/pubmed/34381335
http://dx.doi.org/10.3389/fncel.2021.705618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350727/
https://www.ncbi.nlm.nih.gov/pubmed/34381335
http://dx.doi.org/10.3389/fncel.2021.705618

Ejemplares similares